about
The human steroid hydroxylases CYP1B1 and CYP11B2Treating hypertension while protecting the vulnerable islet in the cardiometabolic syndromeSerum magnesium aberrations in furosemide (frusemide) treated patients with congestive heart failure: pathophysiological correlates and prognostic evaluation.Prevention of remodeling in congestive heart failure due to myocardial infarction by blockade of the renin-angiotensin system.Inhibition of cytochromes p450: existing and new promising therapeutic targets.Evaluation of subacute change in RAAS activity (as indicated by urinary aldosterone:creatinine, after pharmacologic provocation) and the response to ACE inhibition.Exploring QSAR for CYP11B2 binding affinity and CYP11B2/CYP11B1 selectivity of diverse functional compounds using GFA and G/PLS techniques.Can emerging biomarkers of myocardial remodelling identify asymptomatic hypertensive patients at risk for diastolic dysfunction and diastolic heart failure?Low Dose Spironolactone Monotherapy in the Management of Stage I Essential Hypertension: A Pilot Randomized, Double-Blind, Placebo-Controlled Trial.Pharmacophore Modeling and in Silico/in Vitro Screening for Human Cytochrome P450 11B1 and Cytochrome P450 11B2 Inhibitors.
P2860
Q24321759-A677C92E-AB4E-4D1F-BF38-1561D4786E54Q33840829-6D5140CF-C522-4514-844A-2E2D3DF9E256Q35585199-69214785-1953-406E-B9D5-4F57EC2D055FQ36216855-6265B5D5-F568-44E3-879B-BADEDE43DB44Q36929602-1E81BF8E-8DC4-44A7-8A92-56B805147867Q39893116-1403F271-D47B-4E07-91F1-46514D36BDD8Q43210163-537DAD3C-C156-4A4C-9398-ADCBAE411A57Q49106557-4EE54292-129E-4E64-81BE-8E7D4EE8AB68Q49633418-34DA36B5-C0AC-49B7-B12A-A7FFEDDB8B30Q50128659-1A4AA99A-8139-4927-B65A-9086D83F1399
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Spironolactone in congestive heart failure.
@ast
Spironolactone in congestive heart failure.
@en
Spironolactone in congestive heart failure.
@nl
type
label
Spironolactone in congestive heart failure.
@ast
Spironolactone in congestive heart failure.
@en
Spironolactone in congestive heart failure.
@nl
prefLabel
Spironolactone in congestive heart failure.
@ast
Spironolactone in congestive heart failure.
@en
Spironolactone in congestive heart failure.
@nl
P2860
P1476
Spironolactone in congestive heart failure.
@en
P2093
P2860
P2888
P304
P356
10.1007/S11906-000-0027-X
P577
2000-10-01T00:00:00Z
P6179
1031882484